Biosocieties

Papers
(The TQCC of Biosocieties is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Between technology transfer and South–South collaboration: an Indo-Cuban experiment in biopharmaceutical innovation20
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria18
Making pain social: developing a critical social science of pain17
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests16
Horizoning work in a (de-)contaminated village in Fukushima: how are these Japanese urbanites living a normal life there?10
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China9
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation6
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time6
Making sense of snakebite: the place of biological toxins in social scientific analyses of toxicity5
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence5
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies5
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis5
The pharmaceutical commons: conceptual clarifications, a practice example, and a research agenda4
Choreographies of nearness: self and other in personal cancer immune therapy research4
Post-identifiability in changing sociotechnological genomic data environments4
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities4
Data roles: youth mental health outcome measures and the young people who defy them4
Challenges in public policy for the implementation of pharmacogenetic tests in Europe4
Making death through producing life: Necrovalue and the political economy of death3
Introduction to the special issue: The Near Human in life science, biomedicine, and care3
Psychedelic innovations and the crisis of psychopharmacology3
Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building3
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices3
Epistemology of the side effect: anecdote and evidence in the digital age3
Negotiating the necessity of biomedical animal use through relations with vulnerability3
Styles of thought in healthcare governance: A situational analysis of English PrEP discourse 2016–20203
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar3
Turning biodiversity data into evidence: the role of protocols in the epistemology of evidence-based conservation3
Our thanks to founding editor Professor Nikolas Rose3
Processes of encountering: locating urban mental health in the entanglements of weak social relations, material elements and normative orders3
Sanitizing psychedelics: the biopolitics of non-hallucinogenic psychoplastogens3
0.039025068283081